Navigation Links
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for Second Quarter 2013
Date:8/8/2013

br>(0.89)Weighted average number of basic and diluted common shares14,673,77114,554,50214,667,24412,394,869Consolidated Balance Sheets(In thousands) June 30,  December 31, 20132012 (unaudited) Assets:  Cash, cash equivalents, short term investments and restricted cash$
57,306$
75,697  Interest receivable300327  Amounts receivable6,439714  Prepaid expenses and other current assets3,5423,755  Property, equipment and other assets1,7211,523Total assets$
9,308$
82,016Liabilities and stockholders' equity:  Accounts payable and accrued liabilities$
,540$
7,050  Current portion of long-term obligations1,0891,084  Warrant liability1,0873,422  Long term liabilities3,9074,253  Stockholders' equity52,68566,207Total liabilities and stockholders' equity$
9,308$
82,016 

 

 

Conference Call Details OncoGenex will host a conference call at 4:30 p.m. Eastern Time today, Thursday, August 8, 2013, to provide a business update and discuss the second quarter 2013 results.

A live event will be available on the Investor Relations section of the OncoGenex website at www.OncoGenex.com. Alternatively, you may access the live conference call by dialing 877-606-1416 (U.S. & Canada) or 707-287-9313 (International). A replay of the webcast will be available approximately two hours after the call and will be archived for 90 days.

ABOUT ONCOGENEX
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. (NYSE:  TEVA)
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. OncoGenex Announces Multiple Trials in Progress Presentations at the 2013 ASCO Annual Meeting
2. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
3. OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012
4. OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
5. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
6. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
7. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity Growth Conference
8. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
9. Imprimis Pharmaceuticals, Inc. to Present at the Southern California Investor Conference on Thursday, August 8, 2013 at the Island Hotel in Newport Beach, CA. The presentation is scheduled to begin at 11 a.m. ET / 8 a.m. PT
10. OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Optimer Pharmaceuticals, Inc. in Connection with Sale of Company to Cubist Pharmaceuticals, Inc.
11. Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...  Medical Science Liaisons play a large role in ... medical device industry and key stakeholders, the role of ... as the device industry relies on them to build ... benchmarking firm, Best Practices, LLC, one area where Medical ... by harnessing new technology to enable education. Online conferences ...
(Date:12/22/2014)... , Dec. 22, 2014 Apnea Sciences ... corporate offices in Aliso Viejo , ... due to the tremendous growth and worldwide expansion, a ... of patented SnoreRx, the anti snore cure have exceeded ... said, "We are now in 23 countries and ...
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2Investment Analysis of the US Medical Device Sector 2
... Matrixx Initiatives, Inc. (Nasdaq: MTXX ), an over-the-counter healthcare company, announced today ... March 31, 2010 , will be released after the market closes on ... following morning on Tuesday, May 11, 2010 at 11:00 AM ... To access the teleconference, ...
... that a new market research report is available in its catalogue: , ... Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence ... http://www.reportlinker.com/p0191948/Stakeholder-Opinions-Cardiovascular-and-Metabolic-Generics----Generics-continue-to-gain-prominence.html , ... , , , ...
Cached Medicine Technology:Matrixx Initiatives, Inc. Sets Time for Discussion of Fourth Quarter and Fiscal 2010 Financial Results 2Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 2Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 3Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 4Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 5Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 6Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 7Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 8Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence 9
(Date:12/25/2014)... December 26, 2014 Recently, Dylan Queen, ... has excitedly released its collection of discounted prom dresses, ... Percy, a senior spokesman of the company, the promotion ... this promotion is to expand the UK market. , ... several different colors, lengths, and styles: A-line strapless, empire ...
(Date:12/25/2014)... Woodland Hills, California (PRWEB) December 25, 2014 ... in her home in Woodland Hills, California after an ... Harris passed away on Christmas Eve evening in her ... battle with aggressive metastatic breast cancer. ... International for over forty years, she pioneered and championed ...
(Date:12/25/2014)... Dec. 25, 2014 (HealthDay News) -- The risk of ... holidays, so you need to be extra cautious, an ... we see a significant increase in patients coming in ... the Suffolk County Volunteer Firefighters Burn Center of Stony ... should be full of joy, but if not careful, ...
(Date:12/25/2014)... December 25, 2014 AngelWeddingDress.com tries its ... the online realm. Today, the business has introduced its ... site-wide prom dress promotion. , The new prom outfits ... and every dress lover. They are specially designed for ... prom dresses should visit its website before Jan. ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Residents ... Retirement Community, recently showed their generous spirit by ... the Catawba County Parenting Network- Grandparents Raising Grandchildren ... children gathered around the largest Christmas tree on ... presents purchased by residents of the Abernethy Village ...
Breaking Medicine News(10 mins):Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Don't Let Burns Mar Your Holidays 2Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:Retirement Community Residents Make Impact During Holiday Season 2
... Joins Canary,s Board of Directors, SAN JOSE, ... leading regional home improvement retailer, today announced a,partnership ... solely to the funding, discovery and development of,tests ... & CEO,of OSH has been appointed to Canary ...
... more likely to suffer dangerous spike in blood flow ... News) -- Researchers have identified a gene variation in ... physical effects of mental stress that it causes a ... condition called ischemia. , Patients with this particular variation ...
... than before, report shows , , TUESDAY, April 22 (HealthDay ... not rising steadily and uniformly across the United States. ... and 1999, death rates for women went up in ... in life expectancy have worsened across the country. , ...
... An Oregon Health & Science University Cancer Institute ... indicator of survival for men with advanced prostate cancer. ... special type of protein produced by the liver that ... mean that a simple blood test that is already ...
... Robert Wood Johnson Foundations Physician Faculty Scholars program has ... assistant professor of pediatrics at UT Southwestern Medical Center. ... the relationship between infant feeding practices and iron deficiency ... a small group of junior faculty nationwide selected to ...
... prostate cancer more than halved in the Tyrol after a ... the disease, according to research published in April issue of ... 87 per cent of eligible men have been tested at ... 2005 cancer deaths had fallen by 54 per cent, compared ...
Cached Medicine News:Health News:Orchard Supply Hardware Partners With Canary Foundation 2Health News:Orchard Supply Hardware Partners With Canary Foundation 3Health News:Gene Variant Boosts Risk for Stress-Related Ischemia 2Health News:Disparities in Life Expectancy Increasing 2Health News:Disparities in Life Expectancy Increasing 3Health News:OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival 2Health News:UT Southwestern Medical Center receives grant from the Robert Wood Johnson Foundation 2Health News:Prostate cancer screening program leads to bigger fall in death rates than surrounding areas 2Health News:Prostate cancer screening program leads to bigger fall in death rates than surrounding areas 3
... Pediatric Sarmiento-style PTB tibial orthosis ... Lined with closed-cell foam at bony ... Selection of 3 modular footpiece/shoe insert ... patient. Stretch Velcro® design fits especially ...
... Our "Stock Saver" hip abduction orthosis provides the ... Hip with one major difference. Our design innovation ... easily adapted for use in either left or ... lefts and rights. A comfortable neoprene padding is ...
... Brace was developed in collaboration with Dr. ... Disorders at the University of Pittsburgh. The ... abduction and adduction in 15 increments from ... lock in any position from -30 to ...
... Harness™ A Pavlik-type harness with greatly ... treatment of congenital hip dysplasia. Color-coded ... and antislip foot pieces.,Color-coded anterior straps ... can be made while the child ...
Medicine Products: